![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Inc. Featured in the March 11 Issue of the Financial Hub, www.cpreports.com
March 16, 2011 15:57 ET
|
TapImmune Inc.
SEATTLE, March 16, 2011 (GLOBE NEWSWIRE) -- The article (http://www.cpreports.com/?p=931), written by respected business writer Gene Marcial, provides insights into recent progress of TapImmune Inc....
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
Status of Clinical Development Clarification
March 04, 2011 18:32 ET
|
TapImmune Inc.
SEATTLE, March 4, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), wishes to provide a clarification to the Press Release issued on March 1, 2011 'TapImmune Closes $1.16 Million Funding'.
We...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Closes $1.16 Million Funding
March 01, 2011 09:56 ET
|
TapImmune Inc.
SEATTLE, March 1, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce the closing of a $1.16M funding.
On February 24, 2011, we entered into a securities purchase agreement...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Provides Corporate Update
October 14, 2010 08:45 ET
|
TapImmune Inc.
SEATTLE, Oct. 14, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV). Over the last 12 months we have made significant progress in moving TapImmune and its technology platform toward the clinic....
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Appoints New Personnel to Board of Directors and Advisory Team
September 08, 2010 09:15 ET
|
TapImmune Inc.
SEATTLE, Sept. 8, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce the following appointment to its Board of Directors:
Lynn M. DePippo, Founder and Managing Partner,...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Signs Research and Technology License Option Agreement for Smallpox Vaccine
August 04, 2010 09:00 ET
|
TapImmune Inc.
SEATTLE, Aug. 4, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that it has signed a Research and Technology License Option Agreement with Mayo Clinic, Rochester, MN, for the...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Executes a Licensing Option Agreement for a Breast Cancer Vaccine Technology
June 01, 2010 09:00 ET
|
TapImmune Inc.
BELLEVUE, Wash., June 1, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that it has signed an exclusive Licensing Option agreement with Mayo Clinic, Rochester, MN, for clinical...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Closes Institutional Financing Totaling $1.53 Million
May 24, 2010 14:44 ET
|
TapImmune Inc.
BELLEVUE, Wash., May 24, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced today that the Company has completed the sale of Senior Secured Convertible Notes ("Notes") totaling $1.53...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
Tapimmune Inc. Executes a Securities Purchase Agreement for the Issuance of $1.53 Million in Convertible Debt
May 18, 2010 08:00 ET
|
TapImmune Inc.
BELLEVUE, Wash., May 18, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a Nevada corporation, announced today that the Company entered into a definitive purchase agreement on May 17, 2010 with...
![TapImmune Logo](/news-release/logo/216780/0/216780.jpg?lastModified=12%2F09%2F2016%2022%3A52%3A09&size=2)
TapImmune Provides Shareholder Letter
February 23, 2010 07:00 ET
|
TapImmune Inc.
BELLEVUE, Wash., Feb. 23, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), is pleased to provide this corporate update to our shareholders and other interested parties.
With 2010 now out of the...